MED - Medifast, Inc.
NEXT EARNINGS:
May 4, 2026
EPS Est: $-0.52
|
Rev Est: $69.2M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$12.00
DETAILS
HIGH:
$12.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$12.00
UPSIDE:
14.50%
Market Cap:
115.19M
Volume:
255,574
Avg Volume:
260,110
52 Week Range:
10.1-15.48
Sector:
Consumer Cyclical
Industry:
Personal Products & Services
Beta:
0.54
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
504
IPO Date:
1993-12-30
EPS (TTM):
-1.70
P/E Ratio:
-6.28
Revenue (TTM):
385.79M
Total Assets:
257.01M
Total Debt:
16.79M
Cash & Equiv:
89.30M
Rev Growth (5Y):
-16.2%
EPS Growth (5Y):
-50.8%
FCF Growth (5Y):
-61.1%
ROCE:
-6.6%
Debt/Equity:
0.08
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $-0.55 | $-0.76 | +27.6% | $75.1M | $85.5M | -12.2% |
| 2025-11-03 | $-0.21 | $-0.01 | -2000.0% | $89.4M | $71.4M | +25.2% |
| 2025-08-04 | $0.04 | $-0.30 | +113.3% | $105.6M | $93.8M | +12.5% |
| 2025-04-28 | $-0.11 | $-0.07 | -57.1% | $115.7M | $96.1M | +20.4% |
| 2025-02-18 | $0.10 | $-0.16 | +162.5% | $119.0M | $114.2M | +4.2% |
| 2024-11-04 | $0.35 | $-0.15 | +333.3% | $140.2M | $114.2M | +22.7% |
| 2024-08-05 | $0.92 | $0.36 | +155.6% | $168.6M | $174.1M | -3.2% |
| 2024-04-29 | $0.66 | $0.78 | -15.4% | $174.7M | $157.3M | +11.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 385.79M | 602.46M | 1.07B | 1.60B | 1.53B | 934.84M | 713.67M | 501.00M | 301.56M | 274.53M | 272.77M | 285.29M |
| Net Income | (18.67M) | 2.09M | 99.42M | 143.57M | 164.03M | 102.86M | 77.92M | 55.79M | 27.72M | 17.84M | 20.06M | 13.18M |
| EPS | -1.70 | 0.19 | 9.10 | 12.82 | 14.01 | 8.74 | 6.62 | 4.67 | 2.32 | 1.51 | 1.68 | 1.04 |
| Total Assets | 257.01M | 284.21M | 309.91M | 316.21M | 398.33M | 276.08M | 194.65M | 169.43M | 145.93M | 121.22M | 117.33M | 115.91M |
| Total Debt | 16.79M | 16.12M | 22.01M | 26.05M | 32.54M | 11.16M | 13.60M | 0 | 0 | 779,000 | 219,000 | 474,000 |
| Cash & Equivalents | 89.30M | 90.93M | 94.44M | 87.69M | 104.18M | 163.72M | 76.97M | 81.36M | 75.08M | 52.44M | 42.04M | 24.46M |
| Operating Cash Flow | 6.86M | 24.48M | 147.66M | 194.57M | 94.55M | 145.20M | 84.26M | 60.82M | 43.24M | 25.35M | 29.41M | 25.54M |
| Free Cash Flow | 1.25M | 17.02M | 141.17M | 177.89M | 60.34M | 139.31M | 74.20M | 55.88M | 39.99M | 22.47M | 26.59M | 18.51M |
| FCF per Share | 0.11 | 1.56 | 12.97 | 15.89 | 5.15 | 11.83 | 6.30 | 4.68 | 3.35 | 1.90 | 2.22 | 1.46 |
| Book Value | 198.92M | 210.11M | 201.48M | 155.04M | 202.47M | 157.25M | 104.83M | 109.11M | 108.58M | 96.02M | 88.58M | 80.48M |
| Cash & ST Investments | 167.27M | 162.34M | 150.04M | 87.69M | 109.54M | 174.47M | 92.68M | 101.03M | 98.83M | 76.85M | 67.11M | 52.64M |
| ROC Equity | -0.09 | 0.01 | 0.49 | 0.93 | 0.81 | 0.65 | 0.74 | 0.51 | 0.26 | 0.19 | 0.23 | 0.16 |